IA
LLY icon

IndexIQ Advisors’s Eli Lilly LLY Stock Holding History

IndexIQ Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$4.66M Buy
16,276
+436
+3% +$112K 0.17% 118
2021
Q4 		$4.38M Sell
15,840
-278
-2% -$70.5K 0.15% 111
2021
Q3 		$3.72M Buy
16,118
+447
+3% +$110K 0.12% 135
2021
Q2 		$3.6M Buy
15,671
+637
+4% +$128K 0.12% 132
2021
Q1 		$2.81M Buy
15,034
+3,203
+27% +$627K 0.1% 198
2020
Q4 		$2M Buy
11,831
+5,533
+88% +$826K 0.07% 186
2020
Q3 		$932K Buy
6,298
+3,797
+152% +$588K 0.04% 215
2020
Q2 		$411K Buy
2,501
+2,208
+754% +$339K 0.02% 265
2020
Q1 		$41K Sell
293
-1
-0.3% -$137 ﹤0.01% 763
2019
Q4 		$39K Buy
+294
New +$34.1K ﹤0.01% 563

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IndexIQ Advisors's LLY Position: Q1 2022 in Review

IndexIQ Advisors increased its Eli Lilly (LLY) stake by 2.8% in Q1 2022, buying an estimated $112K and bringing the position to 16,276 shares worth $4.66M. The position accounts for 0.17% of the portfolio, ranked #118.

IndexIQ Advisors first reported a position in LLY in Q4 2019 and has held it in 10 quarters since. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • IndexIQ Advisors held 16,276 shares of Eli Lilly worth $4.66M as of Q1 2022.
  • IndexIQ Advisors bought 436 Eli Lilly shares in Q1 2022, an estimated $112K.
  • Eli Lilly made up 0.17% of IndexIQ Advisors's portfolio in Q1 2022, its #118 holding.
  • IndexIQ Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 10 quarters since.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.